Thursday, 20 Feb 2020

RA/Inflammatory arthritis

Date Typesort ascending Title Save
03 Jul 2015 Social RT @DanielHSolomon: Tight control of #RA may also benefit #HeartDisease as noted in @AmerCollRheumatology editorial #rheum #hearthealth htt…
26 Feb 2016 Social New criteria for MAS in systemic JIA 73% sensitive; 99% specific; needs ferritin >684 https://t.co/do32pIrLT6 https://t.co/U6mRtN8XMp
01 Jun 2015 Social Leiden 1007 ERA pts show Rx paradigm changes increased drug free remission w/ early MTX (OR 2.4) or MTX T2T (OR 3.7) http://t.co/CZkwLqrci1
22 Nov 2016 Social Smoking and obesity significant impairs DMARD responses in CATCH study. https://t.co/sfPYRPkd26
05 Mar 2017 Social In TNFi failure RA patients Secukinumab is modestly better than PBO (~30% vs 18%) but not as good as ABAtacept (43%) https://t.co/2Mp9eYs6oY
29 Apr 2017 Social RT @DrRachelTate: Cards pts with poor response to beta-blockers, CCBs, dig - consider AL amyloid. C. Libbey, MD @RheumNow #SOTA2017 https:/…
20 Aug 2017 Social RT @philipcrobinson: How to use meds to treat reflux in scleroderma #SSR17 https://t.co/d8emf6phaf
04 Nov 2017 Social RT @KDAO2011: D P Noble #ACR17 Why UIP in RA is similar to IPF @rheumnow https://t.co/OtBOKvMecP
04 Dec 2017 Social Checkout the #ACR17 video by Dr. Jack Cush on Still's disease and Autoinflammatory Febrile disorders https://t.co/pjrzQlojF7
19 Mar 2018 Social Flares are frequent in patients in 120 RA undergoing arthroplasty (THA, TKA); by 6 wks 63%. Flare more freq with higher disease activity (OR=2), ESR, CRP, Pain; but not affected by biologic use. https://t.co/4hdn5nTQZO
01 Jun 2018 Social German longitudinal study of 953 JIA pts shows that 3 years after Dx 75% achieve improvement and quality of life equal to their non-arthritic normal controls https://t.co/pwUzx5iIx7
22 Jul 2018 Social RA Adherence to1st bDMARD was suboptimal, even in effectively treated pts. In 10374 pts, 1 yr adherence rate = 46%; 2nd Yr = 34%; lowest for golimumab and highest for infliximab. Among 30%, effectively Tx pts, 2yr adherence = 59% https://t.co/35vN57DxRW
22 Oct 2018 Social RT @japaoli19: AbstractL06 Strong ACR 20 responses with Filgotinib in Bio failure population #ACR18 @rheumnow https://t.co/wWwi54tZzU
24 Apr 2019 Social 3002 UK study shows that statin (atorvastatin) use in RA is safe and effective - resulting in significant reduction in Cardiac/MACE events (HR 0.60), LDL (HR 0.77) and CRP and confers a risk reduction similar to that seen in other populations https://t.co/Zl2KaK12P5
15 Jul 2019 Social RT @drpnash: Upadacitinib versus Placebo or Adalimumab in Patients with Rheumatoid Arthritis and an Inadequate Response to Methotrexate:- A…
19 Sep 2019 Social S.Sweden study of ANCA Assoc Vasculitis (GPA, MPA, EGPA) 195 pts followed x8 yrs: found all cancers increased (SIR=2.8). SIR for squamous cell CA=12.9; 4.3 bladder cancer, & 7.0 for pancreatic CA. CYC total <10g were not associated w/ higher CA https://t.co/wqRKaFYWGb
13 Nov 2019 Social RT @psufka: #ACR19 Review Course — Update in RA Therapy 2019 — Dr. Michael Weinblatt. My notes in thread ⬇️⬇️⬇️
07 Jan 2020 Social high-dose trivalent inactivated influenza vaccine (HD-TIV) was studied in 696 RA patients compared to standard-dose quadrivalent flu vaccine - Seroconversion was 3 fold higher w/ HD-TIV, no differences in side effects and no increase in RA flares https://t.co/1JBs95vGSA
15 Feb 2020 Social RT @Janetbirdope: Do you work up pt with frequent infections who has RA SLE or vasculitis? Common variable immune deficiency is .....COMMON…
11 Jun 2015 Social Metabolomics reviewed. These are qualitative & quantitative measures of metabolites of cellular regulatory pathways http://t.co/QmukGxJKfr